|1.||Delgado, René: 8 articles (10/2011 - 05/2005)|
|2.||Pardo-Andreu, Gilberto L: 4 articles (05/2008 - 02/2006)|
|3.||Curti, Carlos: 4 articles (01/2008 - 05/2005)|
|4.||Vercesi, Anibal E: 3 articles (05/2008 - 05/2005)|
|5.||Delgado, R: 3 articles (08/2004 - 12/2003)|
|6.||Leiro, J: 3 articles (08/2004 - 12/2003)|
|7.||García, D: 3 articles (08/2004 - 12/2003)|
|8.||Rivera, Dagmar García: 2 articles (10/2011 - 03/2006)|
|9.||Merino, Nelson: 2 articles (10/2011 - 01/2008)|
|10.||Hernández, Ivones: 2 articles (10/2011 - 01/2008)|
|1.||Body Weight (Weight, Body)
12/01/2003 - "Treatment with Vimang or mangiferin (500 or 50 mg per kg body weight per day, respectively) throughout the parasite life cycle led to a significant decline in the number of parasite larvae encysted in the musculature; however, neither treatment was effective against adults in the gut. "
01/01/2008 - "Serum iron concentration was decreased although at higher doses, Vimang tended to increase it; percent tranferrin saturation, liver weight/body mass ratios, liver iron content was decreased. "
01/01/2008 - "In vivo preventive effects of a Mangifera indica L extract (Vimang) or its major component mangiferin on iron overload injury have been studied in rats given respectively, 50, 100, 250 mg kg(-1) body weight of Vimang, or 40 mg kg(-1) body weight of mangiferin, for 7 days prior to, and for 7 days following the administration of toxic amounts of iron-dextran. "
11/01/2014 - "Here we report that mangiferin (MGF), a natural compound (the predominant constituent of Mangifera indica extract from the plant that produces mango), protected against HFD-induced weight gain, increased aerobic mitochondrial capacity and thermogenesis, and improved glucose and insulin profiles. "
|3.||Asthma (Bronchial Asthma)
03/01/2006 - "Vimang is the brand name of formulations containing an extract of Mangifera indica L., ethnopharmacologically used in Cuba for the treatment of some immunopathological disorders, including bronchial asthma, atopic dermatitis and other allergic diseases. "
10/01/2011 - "The aim was to study the effects of Mangifera indica extract and its major component mangiferin on lung inflammation response and Th2 cytokine production using a murine experimental model of allergic asthma. "
10/01/2011 - "extract (Vimang) and mangiferin reduce the airway inflammation and Th2 cytokines in murine model of allergic asthma."
|4.||Mangifera indica extract